Inhibition of acquired immunodeficiency syndrome virus by oligodeoxynucleoside methylphosphonates.

AUTOR(ES)

Sarin, P S

RESUMO

Antisense oligodeoxynucleotides containing internucleoside methylphosphonate linkages were examined for their ability to inhibit human immunodeficiency virus (HIV)-induced syncytium formation and virus expression. HIV inhibitory activity was found to be dependent on both chain length and the number of phosphonate residues. Introduction of 18 phosphonate groups in an oligomer of chain length 20 significantly increased HIV inhibitory activity relative to the parent oligonucleotide, whereas 5 such groups showed little or no increase in the HIV inhibition capacity. Methylphosphonate-linked oligomers are more stable to nuclease degradation and hence could be potentially useful in the treatment of acquired immunodeficiency syndrome.

Documentos Relacionados

• B- to Z-DNA transition probed by oligonucleotides containing methylphosphonates.
• Use of methylphosphonic dichloride for the synthesis of oligonucleoside methylphosphonates.
• Acquired immunodeficiency syndrome and human immunodeficiency virus infection in Nevada.
• Synthesis of oligodeoxynucleoside methylphosphonates utilizing the tert-butylphenoxyacetyl group for exocyclic amine protection.
• Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation.